Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022116 (
ischemia
)
91,303
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Aminoacyl-tRNA syntheses (AARS) can catalyze the adenosine triphosphate (ATP)-dependent acylation of their cognate tRNA(s) with a specific amino acid. They can be seen as an index to reflect the energy metabolic rate of ischemic brain cells in ischemic penumbra. This study examined the relationship between
arginyl-tRNA synthetase
(
ArgRS
), one of the AARS, and cerebral ischemia in rats. The model of middle cerebral artery occlusion (MCAO) was established in rats. The expression levels of
ArgRS
protein and mRNA were detected in rat brain tissues at different time points following MCAO by Western blotting and RT-PCR, respectively. The results showed that the MCAO model was successfully established. Western blotting and RT-PCR analysis revealed that the
ArgRS
protein and mRNA were expressed in brain cells in both ischemic and normal penumbra tissues. The expression levels of
ArgRS
protein and mRNA peaked at 6 h after MCAO and decreased gradually. At 24 h, the expression levels of ArgRs protein and mRNA in ischemic penumbral tissues were lower than those in normal tissues. The expression levels of
ArgRS
mRNA and protein in ischemic penumbra varied with ischemic time, suggesting that the energy metabolism of brain cells in penumbra changed dynamically after
ischemia
to ensure the endogenous self-protection of the body. The brain oxygen supply should be improved as soon as possible, especially within 6-12 h after
ischemia
, so as to meet the demand for energy metabolism in ischemic penumbra and make sure the cell structure remains stable.
...
PMID:Expression of arginyl-tRNA synthetase in rats with focal cerebral ischemia. 2471 Sep 27
The expression changes of Rars gene in
ischemia
-injured neurons were investigated by detecting its translational product
arginyl-tRNA synthetase
(
ArgRS
), and the inhibitory effects of ischemic preconditioning (IPC) on Rars gene were explored. Both IPC model and prolonged
ischemia
(PI) model were established by using the classic oxygen glucose deprivation (OGD) method. The primary cultured neurons were assigned into the following groups: the experimental group (IPC+PI group), undergoing PI after a short period of IPC; the conditional control group (PI control group), subjected to PI without IPC; blank control group, the normally cultured neurons. The Rars transcriptional activities and
ArgRS
expression levels were measured at different time points after re-oxygenation (3 h/6 h/12 h/24 h). Data were collected and statistically analyzed. Compared to the blank control group, the Rars activities and
ArgRS
levels were significantly increased in PI control group, peaking at the time point of 6 h after re-oxygenation. Rars activities and
ArgRS
levels were significantly lower in the experimental group than in the PI control group at different time points after re-oxygenation. PI insult can induce an escalating activity of Rars and lead to
ArgRS
over-expression in primary cultured neurons. IPC can inhibit the increased Rars activity and down-regulate
ArgRS
expression of
ischemia
-insulted neurons. This mechanism may confer ischemic tolerance on neurons.
...
PMID:Ischemic preconditioning inhibits over-expression of arginyl-tRNA synthetase gene Rars in ischemia-injured neurons. 2746 32